In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of ORIC Pharmaceuticals Inc (NASDAQ: ORIC) was $9.38 for the day, down -3.20% from the previous closing price of $9.69. In other words, the price has decreased by -$3.20 from its previous closing price. On the day, 1.0 million shares were traded. ORIC stock price reached its highest trading level at $9.74 during the session, while it also had its lowest trading level at $9.33.
Ratios:
Our analysis of ORIC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.65 and its Current Ratio is at 14.65. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Evercore ISI on November 20, 2025, initiated with a Outperform rating and assigned the stock a target price of $25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 06 ’25 when Piscitelli Dominic sold 11,000 shares for $14.52 per share. The transaction valued at 159,719 led to the insider holds 48,317 shares of the business.
Chacko Jacob sold 37,461 shares of ORIC for $461,520 on Oct 06 ’25. The PRESIDENT AND CEO now owns 531,419 shares after completing the transaction at $12.32 per share. On Oct 06 ’25, another insider, Dominic Piscitelli, who serves as the Officer of the company, bought 50,000 shares for $14.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 913511488 and an Enterprise Value of 633766464.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.33, which has changed by 0.17597091 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.93, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is -23.50%, while the 200-Day Moving Average is calculated to be -0.59%.
Shares Statistics:
ORIC traded an average of 1.38M shares per day over the past three months and 1247010 shares per day over the past ten days. A total of 97.28M shares are outstanding, with a floating share count of 54.27M. Insiders hold about 44.39% of the company’s shares, while institutions hold 68.87% stake in the company. Shares short for ORIC as of 1764288000 were 17566525 with a Short Ratio of 12.76, compared to 1761868800 on 15494904. Therefore, it implies a Short% of Shares Outstanding of 17566525 and a Short% of Float of 18.270001.
Earnings Estimates
. The current rating of ORIC Pharmaceuticals Inc (ORIC) is the result of assessments by 13.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.3 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$1.48 and -$2.41 for the fiscal current year, implying an average EPS of -$1.63. EPS for the following year is -$1.57, with 13.0 analysts recommending between -$1.22 and -$2.54.
